Path Fertility Releases its Company Facts Sheet

SALT LAKE CITY, UT / ACCESS Newswire / March 10, 2026 / Path FertilityTM, an epigenetics-driven fertility technology company, today unveiled the Path Fertility Facts Sheet, a copy of which is embedded ...
PharmiWeb

For Couples in "Fertility Limbo," a Real-World Study Published by JARG Finds "Normal" Semen ...

A peer-reviewed, multi-clinic study published in the Journal of Assisted Reproduction and Genetics suggests an epigenetic sperm-quality profile can add missing information for infertile couples and ...

Path Fertility: For Couples in "Fertility Limbo," a Real-World Study Published by JARG ...

A peer-reviewed, multi-clinic study published in the Journal of Assisted Reproduction and Genetics suggests an epigenetic sperm-quality profile can add missing information for infertile couples and cl ...

Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment

Enrollment begins in the FDA-authorized FINALE pivotal trial evaluating FemBloc, a first-of-its-kind non-surgical permanent birth control, following positive clinical data -- ATLANTA, March 10, 2026 ...